-
SW033291: 15-PGDH Inhibitor Workflows
2026-08-19
SW033291 is a potent 15-PGDH inhibitor for connecting prostaglandin E2 elevation with hematopoiesis, stem-cell behavior, and tissue repair. This practical guide explains compound handling, enzyme and cell assays, combination studies, and troubleshooting for reproducible regeneration research.
-
Gamithromycin Against MmmSC: In Vitro Pharmacodynamics
2026-08-18
Mitchell and colleagues established a matrix-aware in vitro pharmacodynamic framework for comparing gamithromycin with tylosin and tilmicosin against Mycoplasma mycoides subspecies mycoides Small Colony. The study showed substantially lower apparent MICs in adult bovine serum, while time-kill and post-antibiotic-effect data indicated predominantly static activity and class-dependent persistence.
-
AR Heterogeneity and Enzalutamide Response in Prostate Cance
2026-08-18
The reference study shows that androgen receptor heterogeneity is functionally important in castration-resistant prostate cancer, not merely a descriptive feature. By integrating patient tissues, engineered LNCaP models, xenografts, RNA sequencing, and combination therapy experiments, it connects AR state with enzalutamide response and identifies BCL-2 as a candidate vulnerability.
-
Tropisetron Hydrochloride Assay Workflows
2026-08-17
Tropisetron Hydrochloride enables paired studies of 5-HT3 receptor signaling, α7-nicotinic receptor activity, and renal organic-cation transport. This workflow-focused guide shows how to separate receptor pharmacology from OCT2/MATE1 effects, choose complementary assay formats, and troubleshoot concentration, solubility, and transporter-specific artifacts.
-
Deferasirox Fe3+ Chelate Research Workflow
2026-08-17
Translate ferric-iron binding into reproducible plate, cell, and translational assays with a DMSO-soluble research reagent. This workflow distinguishes preformed Fe3+ complex behavior from free-chelator assumptions while supporting beta-thalassemia and chronic anemia models.
-
Bifendate (DDB): Liver Research Workflows
2026-08-16
Build reproducible liver-injury, lipid-accumulation, and autophagy experiments with Bifendate (DDB). This workflow-centered guide combines practical dosing, assay selection, CYP3A4 interaction controls, and a cautious translation of metabolic insights from a berberrubine NAFLD study.
-
HRD1-SEL1L Control of Stress Granule Homeostasis
2026-08-15
The 2024 iScience study identifies the HRD1-SEL1L ubiquitin ligase complex as a stressor-dependent regulator of heat shock-induced stress granule homeostasis. Its experiments connect ubiquitin-proteasome activity and p97 to the BiP-PERK-eIF2α branch of the unfolded protein response, clarifying how ER stress signaling is coordinated with stress granule dynamics.
-
Oligomycin A and Mitochondrial Energy Failure
2026-08-14
Oligomycin A is a mitochondrial ATP synthase inhibitor that helps distinguish ATP-production failure from upstream mitochondrial dysfunction. This article connects its mechanism to sodium-driven necrosis, assay interpretation, ROS biology, and cancer metabolism research.
-
Structural Tuning of CD38 CAR Binders
2026-08-14
Cheng et al. define how two CD38-targeting CAR binders engage distinct antigen surfaces and couple epitope geometry to enzymatic inhibition, affinity, and cellular behavior. Their structure-guided tuning of 028 reduces CAR-T fratricide while preserving antitumor cytotoxicity, offering a framework for balancing potency with selectivity.
-
JC-1 Mitochondrial Membrane Potential Assay Guide
2026-08-13
The JC-1 Mitochondrial Membrane Potential Assay Kit provides a ratiometric mitochondrial membrane potential assay based on potential-dependent red and green fluorescence. K2002 supports apoptosis assay workflows and mitochondrial function analysis, but its red-to-green ratio is a relative ΔΨm indicator rather than an absolute voltage measurement.
-
Z-IETD-FMK: Translational Control of Cell Fate
2026-08-13
A mechanistic and strategic guide to using Z-IETD-FMK to resolve caspase-8-dependent apoptosis, T cell activation, and TRAIL responses while avoiding overinterpretation of mitochondrial cell-death data.
-
Psora 4 for Reliable Kv1.3 T Cell Assays
2026-08-12
Learn how Psora 4, SKU B7659, can support mechanistically interpretable T-cell proliferation and viability workflows. This scenario-based guide covers assay compatibility, compound preparation, potency variation, and practical product-selection criteria for Kv1.3 research.
-
SB-505124 Hydrochloride: TGF-β Research Workflow
2026-08-12
Build cleaner TGF-β and activin experiments with a reversible ALK4/5/7 inhibitor designed for pathway dissection rather than nonspecific toxicity. This guide connects Smad readouts, fibroblast activation, glaucoma models, and cancer-cell mechanics while highlighting controls that separate signaling effects from solvent or viability artifacts.
-
Methotrexate in Psoriasis Pathway Research
2026-08-11
Explore how Methotrexate can serve as a mechanistic benchmark in psoriasis research, linking DHFR inhibition, immunosuppression, and pathway-level assay design to findings from a recent tanshinone IIA study.
-
Deferasirox Fe3+ Chelate: Assay Workflow Guide
2026-08-09
This scenario-based guide explains how SKU A3355, Deferasirox Fe3+ chelate, can be incorporated into cell viability, proliferation, and cytotoxicity workflows without confusing a preformed ferric complex with free deferasirox. It covers identity confirmation, solvent control, precipitation checks, interpretation, and practical vendor-selection criteria.